Published Study Results

16-yr follow-up data of the European Randomized study of Screening for Prostate Cancer

The ERSPC data with a maximum follow-up of 16 years have previously been published [Hugosson et al., Eur Urol 2019 – doi: 10.1016/j.eururo.2019.02.009].

In the tables presented here, more detailed information on the incidence of prostate cancer and of prostate cancer specific death is presented. Data are tabulated by study arm and further stratified according to age at randomization, Gleason score at time of diagnosis, or cT-stage at time of diagnosis.

In case of any questions, please contact Prof.dr. Monique J. Roobol, principal investigator the ERSPC study by email:

2022-07-28 – Summary ERSPC-data 16 yr (on website)